Lifeward stock price target lowered to $4.50 by H.C. Wainwright

Published 18/11/2025, 13:44
Lifeward stock price target lowered to $4.50 by H.C. Wainwright

Investing.com - H.C. Wainwright lowered its price target on Lifeward (NASDAQ:LFWD) to $4.50 from $13.00 while maintaining a Buy rating, following the company’s third-quarter financial results. The revised target still suggests significant upside potential from the current $0.60 share price, which InvestingPro analysis indicates is trading below its Fair Value despite the stock’s 54% decline over the past six months.

Lifeward reported product revenue of $6.2 million in the third quarter of 2025, slightly below the consensus estimate of $6.3 million, according to the research firm’s report on Tuesday. The company has maintained modest revenue growth of nearly 5% over the last twelve months, despite its challenging market position.

The company’s quarterly sales were partially driven by increased Medicare-related ReWalk sales, with 15 ReWalk units placed in the third quarter of 2025, compared to only 4 units in the same period last year.

This increase in placements translated to $3.1 million in third-quarter ReWalk sales, representing a 24% year-over-year growth from $2.5 million in the third quarter of 2024.

H.C. Wainwright noted that while two quarters of record Medicare placements may be too early to establish a trend, "operational changes, regulatory wins and changes in payor dynamics" underway could support future growth for Lifeward.

In other recent news, Lifeward Ltd reported its Q3 2025 earnings, showcasing a modest revenue increase. The company achieved a revenue of $6.2 million, representing a 1.1% growth compared to the previous year. However, Lifeward faced challenges with profitability, recording an operating loss of $3 million. These financial results highlight the ongoing struggle for the company to achieve sustainable profitability. While the earnings report was released, the stock experienced a slight movement in the premarket. The focus for investors remains on Lifeward’s efforts to improve its financial health. As the company navigates these challenges, stakeholders will be keenly observing any strategic changes or developments in the coming quarters.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.